State Institution Minsk Scientific and Practical Center for Surgery, Transplantology, and Hematology

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Acute lymphoblastic leukaemia1 trial
• Ankylosing spondylitis1 trial
• Multiple myeloma1 trial

Phase

• Phase 1/22 trials
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Enrolling by invitation1 trial
• Recruiting1 trial

Lead sponsor

• Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology2 trials
• Biocad1 trial

Running trials

• Enrolling by invitation

  This is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy for Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma.

  NCT07162571· Phase 1/2· Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology· Source

• Recruiting

  Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma

  NCT07477912· Phase 1/2· Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology· Source

  Contact: Mikhail Uss, MD

• Active, not recruiting

  Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA)

  NCT06333210· Phase 3· Biocad· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia1 recruiting
• Multiple myeloma1 recruiting